Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer

NCT04620603 is registered in ClinicalTrials.gov with Case Comprehensive Cancer Center as lead sponsor.

NCT NCT04620603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04620603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in Cancer
Lead sponsor
Case Comprehensive Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
May 27, 2021
Completion date
September 1, 2026
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cutaneous malignant melanoma, renal cell cancer, urothelial cancer of renal pelvis